Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Pharmaceutical Technology

MAY 25, 2023

There was no significant difference in side effect profiles of the two vaccines, based on the data. The World Health Organization (WHO) has set a goal of ending the meningitis epidemic by 2030. The overall difference in seroresponses to the two vaccines for the four shared serogroups ranged from 1.2 for serogroup W to 20.5

Side effects 78

Side effects Medicine Safety Marketing 78

pharmaphorum

SEPTEMBER 16, 2022

The company hopes to show in its phase 3 trial that GMRx2 can boost adherence, increase efficacy, and reduce side effects, compared to antihypertensive medicines given separately, and is targeting a launch of the drug in 2023. By 2030, it is projected that over 215 million Africans will have hypertension.

Side effects 52

Side effects Medicine Healthcare Provider Patients 52

pharmaphorum

DECEMBER 21, 2022

Likewise, between 2030 and 2050, the World Health Organization estimates that climate change will be responsible for around 250,000 additional deaths per year. Innovation – using technology to solve problems without creating harmful side-effects. Mission – embedding purpose and upholding ethics across every area of a business.

Side effects 98

Side effects Healthcare Healthcare Ethics 98

Pharmaceutical Technology

AUGUST 26, 2022

This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. As patients with a drug-resistant form of TB cannot receive the standard regimen, their treatment courses tend to be more complex and often cause unsavoury side effects.

Side effects 98

Side effects Pharmaceutical Patients Recruitment 98

European Pharmaceutical Review

MARCH 24, 2023

Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) side effects. In the European Union, NASH affects nearly 10 million people and is expected to increase by more than 40 percent by 2030. It is becoming the leading cause for liver transplants.

Medical 108

Medical Side effects Safety Pharmaceutical 108

PM360

AUGUST 9, 2022

billion in 2030 at a CAGR of 9.2%. This allows patients to complete the whole treatment process, from drug preparation and drug administration to treatment monitoring, side effect reporting, and communication, with one click on their device and smartphone. from 2021 and reach $4.2 billion in 2025.

Prescription 105

Prescription Medical Patients Side effects 105

European Pharmaceutical Review

OCTOBER 24, 2024

Nevertheless, both efficiently clear amyloid and have a similar slowing effect on progression of cognitive decline in patients”. However, side effects of these drugs, such as “the development of amyloid-related imaging abnormalities (ARIAs), remains a significant concern”. billion in 2030, respectively.” billion and $2.0

Food and Drug Administration 52

Food and Drug Administration Side effects Medicine Patients 52

Celeritas

MARCH 3, 2023

Because drugs aren’t personalized, they often have irregular side effects. By 2030 it is predicted to rise by as much as 20% annually and most of this protein is sourced from the ocean. This accelerates the rate of drug discovery while lowering the cost and raising the efficacy of control studies and treatment trials.

Food 98

Food Training Management Prescription 98

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe side effects. from 2023 to 2030. Poised to grow at a CAGR of 29.4% The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52

Pharma Medicine Marketing Prospecting 52

Clarify Health

OCTOBER 3, 2023

billion by 2030, according to Grand View Research, Inc., In drug research and personalized medicine, AI algorithms sift through intricate genetic information to recommend treatments tailored for individual patients, increasing the efficacy and reducing potential side effects. and reported by Bloomberg.

Healthcare 59

Healthcare Healthcare Patients Side effects 59

pharmaphorum

SEPTEMBER 30, 2022

GlobalData notes that the side effect could be a barrier for lecanemab use as it will require patient monitoring, but points out that the rates are a “significant improvement” on Aduhelm, which had an ARIA-E rate of 35% of patients taking the approved dose in clinical trials. .”

Doctors 52

Doctors Side effects Sales Safety 52

Clarivate

AUGUST 17, 2022

Also listed as a target is reducing premature deaths from non-communicable diseases by one third by 2030. What side effects should you contact a doctor about immediately, or what are the risks of a procedure and the likelihood of success? Supporting patients at the point of care.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

Celeritas

SEPTEMBER 26, 2022

The QR code payment market is projected to rise to $35 billion by 2030. This will confirm the company name alongside the date of expiry, contents, and possible side effects. QR codes emerged in the 90s with a few basic use cases and very few users. This is especially useful when following a complex medical regimen.

Physicians 52

Physicians Patients Medical Management 52

Celeritas

SEPTEMBER 25, 2022

The QR code payment market is projected to rise to $35 billion by 2030. This will confirm the company name alongside the date of expiry, contents, and possible side effects. QR codes emerged in the 90s with a few basic use cases and very few users. This is especially useful when following a complex medical regimen.

Insurance 52

Insurance Management Medical Marketing 52

Pharmaceutical Technology

JANUARY 11, 2023

By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Funding has followed the technology, with the digital health sector seeing significant growth globally due to strong investor confidence and perceived investment opportunities.

Healthcare 52

Healthcare Healthcare Medical Electronics 52